AzTrials
AzTrials

Duchenne Muscular DystrophyNCT05249361

Correlation Between Functional Capacity and Functional Capability in Duchenne Muscular Dystrophy

An observational study of Duchenne Muscular Dystrophy, run by Samsung Medical Center at 2 sites in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study investigates the correlation between assessments measuring functional capacity and functional capability in patients with Duchenne muscular dystrophy. Read more about this study

Who is it for?
Ages 5 to 18 years
Conditions the study is for
Duchenne Muscular Dystrophy
How many people
48 participants
Where
2 sitesSouth Korea
Study dates
1 May 2023to 1 Oct 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 18 years
  • All sexes
  • Child, Adult

Study population: Asian patients of Duchenne muscular dystrophy, who live in South Korea and visited the Samsung medical center in Gangnam-gu, Seoul.

Who may be able to join

  • Children aged 5 to 18 years diagnosed with Duchenne muscular dystrophy through genetic testing
  • Children who understand the contents of this research and can properly conduct the research

Who cannot join

  • Requiring daytime ventilator assistance or using invasive mechanical ventilation through tracheostomy (Non-invasive mechanical ventilation such as positive pressure ventilation at night is allowed)
  • History of peripheral nerve damage
  • History of major surgery within 12 weeks or if major surgery is expected during the test period
  • History of central nervous system disorders (eg, cerebral infarction, spinal cord injury)
  • Having difficulties in conducting this study due to cognitive decline.

Trial locations and contacts

2 sites in 1 country.

South Korea2 sites, 2 recruiting
  • Samsung Medical Center

    Seoul, 06135

    Yumi Choe, +8231732671, yumi.choe@sbri.co.kr

    Recruiting
  • Samsung Medical Center

    Seoul, 06351

    JEONG-YI KWON, MD, PHD, +8210-4591-1039, jeongyi.kwon@samsung.com

    JEONG-YI KWON, MD

    Recruiting

Other trials in South Korea

About this study

Official title: Correlation Between Functional Capacity and Functional Capability in Patients With Duchenne Muscular Dystrophy-A Longitudinal Study

This study investigates the correlation between assessments measuring functional capacity and functional capability in patients with Duchenne muscular dystrophy.

Read the detailed description

This study is a prospective single-arm observational study, with a total of two visits for one year follow-up.

Being tested
no intervention
Keywords
Duchenne Muscular Dystrophy, DMD, Accelerometer, ActiGraph, DEXA, muscle ultrasound
Medical subject headings
Muscular Dystrophy, Duchenne

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • no interventionOther

    no intervention

Study groups in NCT05249361
Study groupRoleWhat they receive
Duchenne Muscular DystrophyChildren aged 5 to 18 years with Duchenne muscular dystrophy
Receives: Other: no intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correlation between physical activity(VM) and muscle quantitative index

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in muscle quantitative measures of upper and lower extremities from baseline to 48-week. The activity counts will be measured with ActiGraph wgt3x-bt worn on patient's dominant ankle and wrist. Accelerometers recorded acceleration in three orthogonal axes (x, y, z) at 30 Hz. Accelerometer recordings were uploaded to ActiLife software, integrated into 15-second epochs, and converted into an omnidirectional acceleration estimate, or vector magnitude (VM), calculated as the square root of the sum of the triaxial signals squared.

    The muscle quantitative will be measured with Microfet2. Muscle quantitative of upper extremity is the sum of the flexion and extension of both elbows and lower extremity is the sum of both knee flexion and extension and bilateral ankle dorsiflexion.

    Measured: Baseline up to Week 48

Secondary outcomes (11)
  1. Correlation between physical activity and Vignos scale

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in Vignos scale score from baseline to 48-week. On the Vignos scale, the grade ranges from 1 to 10; 1 means that the patient is able to walk and climb stairs without assistance, while 10 means that the patient is bed-bound

    Measured: Baseline up to Week 48

  2. Correlation between physical activity and Brooke scale

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in Brooke scale score from baseline to 48-week. The grades on the Brooke scale range from 1 to 6; 1 means that the patient is able to start with arms at the sides and can abduct the arms in a full circle until they touch above the head, while 6 means that they are unable to raise their hands to their mouth and have no useful function of the hands.

    Measured: Baseline up to Week 48

  3. Correlation between physical activity and 6MWT(6-minute walking test)

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in 6MWT results from baseline to 48-week. The 6MWT assesses distance walked over 6 minutes.

    Measured: Baseline up to Week 48

  4. Correlation between physical activity and NSAA(The North Star Ambulatory Assessment)

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in NSAA scores from baseline to 48-week. The NSAA is a 17-item rating scale that is used to measure functional motor abilities in ambulant children with Duchenne Muscular Dystrophy (DMD). It includes several items assessing abilities that are necessary to remain functionally ambulant, items assessing abilities, such as head raise and standing on heels that can be partly present in the early stages of the disease and a number of activities such as hopping.

    Each item can be scored on a 3 point scale using simple criteria: 2 -Normal achieves goal without any assistance; 1 -Modified method but achieves goal independent of physical assistance from another person; 0 -Unable to achieve independently.

    A total score can be achieved by summing the scores for all the individual items. The score can range from 0, if all the activities are failed, to 34, if all the activities are achieved.

    Measured: Baseline up to Week 48

  5. Correlation between physical activity and PUL(Performance of Upper Limb module for DMD)

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in PUL scores from baseline to 48-week.

    The PUL includes 22 items with an entry item to define the starting functional level (which corresponds to the Brooke scale) and 21 items subdivided into shoulder level (4 items), elbow level (9 items), and distal (i.e., wrist and fingers) level (8 items). For weaker patients, a low score on the entry item (i.e., less than 4 point of Item A) means that shoulder-level items do not need to be performed. Each dimension can be scored separately with a maximum score of 16 for the shoulder level, 34 for the elbow level, and 24 for the distal level. A total score can be achieved by adding the three-level scores, with a maximum global score of 74 points.

    Measured: Baseline up to Week 48

  6. Correlation between physical activity and PEDI-CAT(the Pediatric Evaluation of Disability Inventory-Computer Adaptive Test)

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in mobility and self-care domain scores of PEDI-CAT from baseline to 48-week.

    Te PEDI-CAT incorporates a computer-adaptive platform with 276 items based on parental or caregiver reporting, and has four domains that cover daily activities, mobility, social/cognitive function, and responsibility. The PEDI-CAT yields a single score scaled from 0 to 100 for both Mobility and Self-care, with higher scores indicating greater function.

    Measured: Baseline up to Week 48

  7. Correlation between physical activity and EQ-5D(EuroQol-5D)

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in EQ-5D from baseline to 48-week.

    EuroQol EQ-5D is a preference-based HRQOL measurement tool for the five dimensions of 'exercise ability', 'self-management', 'daily activity', 'pain/discomfort', and 'anxiety/depression' in terms of 'no problem', 'somewhat Evaluated on three levels of 'having a problem' and 'having a serious problem', and the overall level was evaluated on a thermometer-shaped 20 cm vertical visual analogue scale with 0 points for the lowest health and 100 points for the highest health status.

    Measured: Baseline up to Week 48

  8. Correlation between physical activity and CHQ-PF50(Child Health Questionnaire - Parent form 50 )

    We analyze the correlation between the change in activity counts from baseline to 48-week and the change in EQ-5D from baseline to 48-week.

    The Child Health Questionnaire - Parent form 50 (CHQ-PF50) consists of 50 questions and 12 scales (Physical function, Role/social limitations-physical, Role/social limitations-emotional/ behavioral, Mental health, Self-esteem, Behavior, Bodily pain/discomfort, General health perceptions, Family activities, Parent impact on time, Parent emotional impact) and 2 global items (Global behavior and global general health), 2 summary scores (Physical and a psychosocial summary scores) is a tool to evaluate the quality of life of children. The raw score is converted into a converted score between 0-100, and the higher the score, the better the quality of life.

    Measured: Baseline up to Week 48

  9. Correlation between physical activity and quantitative muscle ultrasonography

    We analyze the correlation between change in activity from baseline to 48-week and the change in quantitative muscle ultrasonography from baseline to 48-week. We will measure the echogenicity of the muscles at 12 sites including deltoid, biceps brachii, wrist/finger flexors, rectus femoris, tibialis anterior, medial gastrocnemius, masseter, sternocleidomastoid, geniohyoid and diaphragm. The average gray scale of above muscles will be analyzed with ImageJ software (https://imagej.nih.gov).

    Measured: Baseline up to Week 48

  10. Correlation between physical activity and DMD upper limb PROM

    We analyze the correlation between change in activity from baseline to 48-week and the change in DMD upper limb PROM from baseline to 48-week. DMD upper limb PROM is a patient reported outcome measure designed to assess upper extremity performance in daily life. It includes 32 items and each item will be scored on a 3 point scale: 2-can do task easily; 1-can do tast with difficulty; 0-impossible without help. A total score is the summation of the scores for all individual items. The score can range from 0 to 64.

    Measured: Baseline up to Week 48

  11. Correlation between physical activity and Pulmonary function test

    We analyze the correlation between change in activity from baseline to 48-week and the change in pulmonary function test from baseline to 48-week. Maximal inspiratory pressure and maximal expiratory pressure will be measured with spirometry (Spirovis, Cosmed Srl, Rome, Italy).

    Measured: Baseline up to Week 48

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2022
  2. Study start1 May 2023
  3. Primary completion1 Apr 2025 (estimated)
  4. Study completion1 Oct 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05249361
Sponsor's protocol ID
2022-05-136
Status last verified
Nov 2023
First submitted
10 Feb 2022
Last updated
29 Nov 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Im YJ, Choe Y, Lee J, Lee J, Do JG, Kwon JY. Quantitative Muscle Ultrasound: A Non-Invasive Biomarker for Monitoring Duchenne Muscular Dystrophy. Muscle Nerve. 2025 Oct;72(4):606-615. doi: 10.1002/mus.28469. Epub 2025 Jul 16.

    PubMed 40671379

Questions about this trial

What is this clinical trial studying?

An observational study of Duchenne Muscular Dystrophy, run by Samsung Medical Center at 2 sites in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yumi Choe (82-010-3173-2671, yumi.choe@sbri.co.kr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correlation between physical activity(VM) and muscle quantitative index (time frame: Baseline up to Week 48). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05249361, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in